{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:06:39Z","timestamp":1768323999029,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.mehy.2020.110330","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T11:22:31Z","timestamp":1601551351000},"page":"110330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Viral replication of SARS-CoV-2 could be self-limitative \u2013 The role of the renin-angiotensin system on COVID-19 pathophysiology"],"prefix":"10.1016","volume":"145","author":[{"given":"Vinicius","family":"Novaes Rocha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110330_b0005","doi-asserted-by":"crossref","DOI":"10.23736\/S0026-4806.20.06603-3","article-title":"Covid-19 brings the world economy to its knees","author":"Fagoonee","year":"2020","journal-title":"Minerva Med"},{"issue":"5","key":"10.1016\/j.mehy.2020.110330_b0010","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41591-020-0863-y","article-title":"If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future","volume":"26","author":"McKee","year":"2020","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.mehy.2020.110330_b0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0141076820925229","article-title":"Developing a sustainable exit strategy for COVID-19: health, economic and public policy implications","volume":"113","author":"Anderson","year":"2020","journal-title":"J R Soc Med"},{"issue":"25","key":"10.1016\/j.mehy.2020.110330_b0020","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin\u2013Angiotensin\u2013Aldosterone System Blockers and the Risk of Covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.mehy.2020.110330_b0025","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013Angiotensin\u2013Aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110330_b0030","doi-asserted-by":"crossref","unstructured":"Xiao L, Sakagami H, Miwa N. ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? Viruses. 04 2020;12(5)doi:10.3390\/v12050491.","DOI":"10.3390\/v12050491"},{"key":"10.1016\/j.mehy.2020.110330_b0035","doi-asserted-by":"crossref","unstructured":"Liabeuf S, Moragny J, Bennis Y, et al. Association between renin-angiotensin system inhibitors and COVID-19 complications. Eur Heart J Cardiovasc Pharmacother. Jun 2020;doi:10.1093\/ehjcvp\/pvaa062.","DOI":"10.1093\/ehjcvp\/pvaa062"},{"key":"10.1016\/j.mehy.2020.110330_b0040","doi-asserted-by":"crossref","unstructured":"K. Lanza L.G. Perez L.B. Costa T.M. Cordeiro V.A. Palmeira V.T. Ribeiro A.C. Sim\u00f5es e Silva Covid-19: the renin\u2013angiotensin system imbalance hypothesis 134 11 2020 2020 1259 1264 https:\/\/portlandpress.com\/clinsci\/article\/134\/11\/1259\/225184\/Covid19-the-reninangiotensin-system-imbalance.","DOI":"10.1042\/CS20200492"},{"key":"10.1016\/j.mehy.2020.110330_b0045","doi-asserted-by":"crossref","unstructured":"Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. Sep 2008;264(3):224-36. doi:10.1111\/j.1365-2796.2008.01981.x.","DOI":"10.1111\/j.1365-2796.2008.01981.x"},{"issue":"5","key":"10.1016\/j.mehy.2020.110330_b0050","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A Novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.mehy.2020.110330_b0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1139\/y02-021","article-title":"ACEH\/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors","volume":"80","author":"Turner","year":"2002","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2020.110330_b0060","doi-asserted-by":"crossref","first-page":"L84","DOI":"10.1152\/ajplung.00071.2009","article-title":"Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia","volume":"297","author":"Jia","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"14","key":"10.1016\/j.mehy.2020.110330_b0065","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.mehy.2020.110330_b0070","doi-asserted-by":"crossref","unstructured":"Vaduganathan M, Solomon SD. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply. N Engl J Med. 06 2020;382(24):e92. doi:10.1056\/NEJMc2013707.","DOI":"10.1056\/NEJMc2013707"},{"key":"10.1016\/j.mehy.2020.110330_b0075","doi-asserted-by":"crossref","unstructured":"Belouzard S, Millet JK, Licitra BN, Whittaker GR. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 06 2012;4(6):1011-33. doi:10.3390\/v4061011.","DOI":"10.3390\/v4061011"},{"key":"10.1016\/j.mehy.2020.110330_b0080","doi-asserted-by":"crossref","unstructured":"Milewska A, Nowak P, Owczarek K, et al. Entry of Human Coronavirus NL63 into the Cell. J Virol. 02 2018;92(3)doi:10.1128\/JVI.01933-17.","DOI":"10.1128\/JVI.01933-17"},{"issue":"24","key":"10.1016\/j.mehy.2020.110330_b0085","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"JVI"},{"key":"10.1016\/j.mehy.2020.110330_b0090","doi-asserted-by":"crossref","first-page":"104792","DOI":"10.1016\/j.antiviral.2020.104792","article-title":"Coronavirus membrane fusion mechanism offers a potential target for antiviral development","volume":"178","author":"Tang","year":"2020","journal-title":"Antiviral Res"},{"issue":"9371","key":"10.1016\/j.mehy.2020.110330_b0095","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110330_b0100","doi-asserted-by":"crossref","unstructured":"van der Hoek L, Sure K, Ihorst G, et al. Croup is associated with the novel coronavirus NL63. PLoS Med. Aug 2005;2(8):e240. doi:10.1371\/journal.pmed.0020240.","DOI":"10.1371\/journal.pmed.0020240"},{"key":"10.1016\/j.mehy.2020.110330_b0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijid.2020.03.071","article-title":"Insight into 2019 novel coronavirus \u2014 An updated interim review and lessons from SARS-CoV and MERS-CoV","volume":"94","author":"Xie","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.mehy.2020.110330_b0110","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mehy.2020.110330_b0115","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/JVI.01248-09","article-title":"Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63","volume":"84","author":"Glowacka","year":"2010","journal-title":"JVI"},{"key":"10.1016\/j.mehy.2020.110330_b0120","doi-asserted-by":"crossref","unstructured":"Xia X. Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense. Mol Biol Evol. Apr 2020;doi:10.1093\/molbev\/msaa094.","DOI":"10.1093\/molbev\/msaa094"},{"key":"10.1016\/j.mehy.2020.110330_b0125","doi-asserted-by":"crossref","unstructured":"Chu H, Chan JF, Wang Y, et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis. Apr 2020;doi:10.1093\/cid\/ciaa410.","DOI":"10.1093\/cid\/ciaa410"},{"issue":"76","key":"10.1016\/j.mehy.2020.110330_b0130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"06","author":"Verdecchia","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.mehy.2020.110330_b0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","article-title":"Targeting the renin-angiotensin-aldosterone system in fibrosis","volume":"91-92","author":"AlQudah","year":"2020","journal-title":"Matrix Biol"},{"issue":"7047","key":"10.1016\/j.mehy.2020.110330_b0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mehy.2020.110330_b0145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110330_b0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/978-981-10-3233-2_27","article-title":"Roles of RUNX in hypoxia-induced responses and angiogenesis","volume":"962","author":"Lee","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mehy.2020.110330_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/584758","article-title":"Hypoxia inducible factor pathway and physiological adaptation: a cell survival pathway?","volume":"2015","author":"Kumar","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.mehy.2020.110330_b0160","doi-asserted-by":"crossref","first-page":"L631","DOI":"10.1152\/ajplung.90415.2008","article-title":"Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells","volume":"297","author":"Zhang","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.mehy.2020.110330_b0165","doi-asserted-by":"crossref","first-page":"L547","DOI":"10.1152\/ajplung.00387.2018","article-title":"MiRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2","volume":"316","author":"Zhang","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.mehy.2020.110330_b0170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.mehy.2020.110330_b0175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.mehy.2020.110330_b0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"10.1016\/j.mehy.2020.110330_b0185","doi-asserted-by":"crossref","DOI":"10.1038\/srep31912","article-title":"AAV8-mediated angiotensin-converting enzyme 2 gene delivery prevents experimental autoimmune uveitis by regulating MAPK, NF-\u03baB and STAT3 Pathways","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci Rep"},{"issue":"16","key":"10.1016\/j.mehy.2020.110330_b0190","doi-asserted-by":"crossref","first-page":"7448","DOI":"10.7150\/thno.48076","article-title":"SARS-CoV-2 pandemic and research gaps: understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy","volume":"10","author":"Datta","year":"2020","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.mehy.2020.110330_b0195","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.RES.0000217340.40936.53","article-title":"Signaling by the angiotensin-converting enzyme","volume":"98","author":"Fleming","year":"2006","journal-title":"Circ Res"},{"issue":"30","key":"10.1016\/j.mehy.2020.110330_b0200","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/0929867324666170414162841","article-title":"Circulating ACE2 in cardiovascular and kidney diseases","volume":"24","author":"Anguiano","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.mehy.2020.110330_b0205","doi-asserted-by":"crossref","unstructured":"Ortiz-P\u00e9rez JT, Riera M, Bosch X, et al. Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study. PLoS One. 2013;8(4):e61695. doi:10.1371\/journal.pone.0061695.","DOI":"10.1371\/journal.pone.0061695"},{"key":"10.1016\/j.mehy.2020.110330_b0210","doi-asserted-by":"crossref","unstructured":"Dijkman R, Jebbink MF, Deijs M, et al. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. J Gen Virol. Sep 2012;93(Pt 9):1924-1929. doi:10.1099\/vir.0.043919-0.","DOI":"10.1099\/vir.0.043919-0"},{"issue":"6","key":"10.1016\/j.mehy.2020.110330_b0215","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1128\/JVI.79.6.3846-3850.2005","article-title":"Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication","volume":"79","author":"Mossel","year":"2005","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.mehy.2020.110330_b0220","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mehy.2020.110330_b0225","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.kint.2020.04.009","article-title":"Blockade of SARS-CoV-2 infection by recombinant soluble ACE2","volume":"97","author":"Alhenc-Gelas","year":"2020","journal-title":"Kidney Int"},{"issue":"23","key":"10.1016\/j.mehy.2020.110330_b0230","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"JVI"},{"issue":"4","key":"10.1016\/j.mehy.2020.110330_b0235","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1189\/jlb.72.4.711","article-title":"Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163","volume":"72","author":"Hintz","year":"2002","journal-title":"J Leukoc Biol"},{"issue":"13","key":"10.1016\/j.mehy.2020.110330_b0240","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.18632\/aging.103579","article-title":"Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis","volume":"12","author":"Fang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.mehy.2020.110330_b0245","doi-asserted-by":"crossref","unstructured":"Poblador-Plou B, Carmona-P\u00edrez J, Ioakeim-Skoufa I, et al. Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain. Int J Environ Res Public Health. 07 2020;17(14)doi:10.3390\/ijerph17145171.","DOI":"10.3390\/ijerph17145171"},{"issue":"10","key":"10.1016\/j.mehy.2020.110330_b0250","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.numecd.2009.06.011","article-title":"ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study","volume":"20","author":"Junyent","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.mehy.2020.110330_b0255","doi-asserted-by":"crossref","first-page":"F333","DOI":"10.1152\/ajprenal.00625.2018","article-title":"Role of ADAM17 in kidney disease","volume":"317","author":"Palau","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.mehy.2020.110330_b0260","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.atherosclerosis.2015.01.029","article-title":"A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis","volume":"239","author":"Rizza","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2020.110330_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1067134","article-title":"The EGFR-ADAM17 axis in chronic obstructive pulmonary disease and cystic fibrosis lung pathology","volume":"2018","author":"Stolarczyk","year":"2018","journal-title":"Mediators Inflamm"},{"issue":"11","key":"10.1016\/j.mehy.2020.110330_b0270","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.bbamcr.2017.07.001","article-title":"The shedding protease ADAM17: Physiology and pathophysiology","volume":"1864","author":"Zunke","year":"2017","journal-title":"Biochim Biophysi Acta (BBA) \u2013 Molecular Cell Research"},{"issue":"34","key":"10.1016\/j.mehy.2020.110330_b0275","doi-asserted-by":"crossref","first-page":"30113","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)","volume":"280","author":"Lambert","year":"2005","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.mehy.2020.110330_b0280","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/j.1432-1033.2004.04184.x","article-title":"The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein","volume":"271","author":"Allinson","year":"2004","journal-title":"Eur J Biochem"},{"issue":"1","key":"10.1016\/j.mehy.2020.110330_b0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(98)00726-1","article-title":"The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-alpha convertase","volume":"431","author":"Parvathy","year":"1998","journal-title":"FEBS Lett"},{"issue":"Pt A","key":"10.1016\/j.mehy.2020.110330_b0290","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 receptor signaling pathways in the cardiovascular system","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.mehy.2020.110330_b0295","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","article-title":"Gender and the renin-angiotensin-aldosterone system","volume":"24","author":"Komukai","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.mehy.2020.110330_b0300","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/ndt\/gfv025","article-title":"Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease","volume":"30","author":"Anguiano","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.mehy.2020.110330_b0305","doi-asserted-by":"crossref","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 Among Children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.mehy.2020.110330_b0310","article-title":"Comorbidities and mortality in patients with COVID-19 aged 60 years and older in a university hospital in spain","author":"Posso","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.mehy.2020.110330_b0315","article-title":"Risks to children during the covid-19 pandemic: some essential epidemiology","volume":"369","author":"Bhopal","year":"2020","journal-title":"BMJ"},{"issue":"Suppl 3","key":"10.1016\/j.mehy.2020.110330_b0320","first-page":"1","article-title":"COVID-19 in children: epidemiology, presentation, diagnosis and management","volume":"70","author":"Khan","year":"2020","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"10.1016\/j.mehy.2020.110330_b0325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbrc.2020.03.047","article-title":"Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection","volume":"526","author":"Luan","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2020.110330_b0330","unstructured":"T.H.C. Sit C.J. Brackman S.M. Ip K.W.S. Tam P.Y.T. Law E.M.W. To V.Y.T. Yu L.D. Sims D.N.C. Tsang D.K.W. Chu R.A.P.M. Perera L.L.M. Poon M. Peiris Infection of dogs with SARS-CoV-2 10.1038\/s41586-020-2334-5 http:\/\/www.nature.com\/articles\/s41586-020-2334-5."},{"issue":"5","key":"10.1016\/j.mehy.2020.110330_b0335","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10741-019-09797-y","article-title":"Levels of angiotensin peptides in healthy and cardiovascular\/renal-diseased paediatric population\u2014an investigative review","volume":"24","author":"Suessenbach","year":"2019","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10.1016\/j.mehy.2020.110330_b0340","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00380-019-01478-y","article-title":"Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1\u20137)-MAS axis and coronary heart disease","volume":"35","author":"Zhou","year":"2020","journal-title":"Heart Vessels"},{"issue":"7","key":"10.1016\/j.mehy.2020.110330_b0345","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2016.11.064","article-title":"Roles of angiotensin peptides and recombinant human ACE2 in heart failure","volume":"69","author":"Basu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2020.110330_b0350","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2016.08.032","article-title":"Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease","volume":"253","author":"Anguiano","year":"2016","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.mehy.2020.110330_b0355","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/jvim.15548","article-title":"Plasma and tissue angiotensin\u2010converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease","volume":"33","author":"Larouche\u2010Lebel","year":"2019","journal-title":"J Vet Intern Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720320818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720320818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:21:51Z","timestamp":1759692111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720320818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":71,"alternative-id":["S0306987720320818"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110330","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral replication of SARS-CoV-2 could be self-limitative \u2013 The role of the renin-angiotensin system on COVID-19 pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110330"}}